Next Article in Journal
Ratio Derivative S~ectrophotometricM ethod for the Determination of Some Oxicams in Presence of their Alkaline Dearadation Products
Previous Article in Journal
Struktur und Eigenschaften des Benzidinblau-Chromophors N,N'-unsubstituierter Benzidine
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development of Buccoadhesive Systems of Pentarocine for Systemic Drug Delivery

by
D. Sampathkumar
1,2,
M. Thilek Kumar
2,
J. Balasubrarnaniam
2,3,4,* and
J. K. Pandit
2
1
Present address, Orchid chemicals and pharmaceutical Limited, Chennai, Tamil Nadu, lndia
2
Department of Pharmaceutics, Institute of Technology, Banaras Hindu University Varanasi- 221 005, Utter.Pradesh., lndia
3
Present address: Ranbaxy Research Laboratories, 77-8, IFFCO Road, Sector-18, Gurgaon-I 22001, Haryana, lndia
4
Research and Development (R&D IV, IP Cell), Ranbaxy Research Laboratories, 77- B, IFFCO Road, Sector-1 8, Gurgaon-122001, Haryana, lndia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2003, 71(4), 281-301; https://doi.org/10.3797/scipharm.aut-03-25
Submission received: 23 June 2003 / Revised: 30 September 2003 / Accepted: 30 September 2003 / Published: 15 October 2003

Abstract

Bucoadhesive patches of Pentazocine (PZ) for unidirectional drug delivery were prepared by casting carboxy methyl cellulose (CMC) with glycerol or propylene glycol and CMC-hydroxy ethyl cellulose (HEC) with glycerol. In vitro mucoadhesivity of the prepared patches were determined using a modified mucoadhesive bond strength apparatus using rabbit small intestine mucosa (SIM). Drug release kinetics was evaluated from composite patches, prepared by covering all but one side of the PZ patches with 3M backing material. Biocompatability / buccoadhesion time and in vivo permeation of placebo and PZ loaded patches were determined using a double blind cross over study in healthy human volunteers. Drug release from CMC-glycerol patches and pure HEC patches showed zero order kinetics with diffusional exponent (n) ranging between 0.79 to 1.046, while that from CMC-HEC and CMC-propylene glycol patches showed an apparent zero order release kinetics. The prepared patches were well tolerated by the human volunteers as they did not produce any side effects at the contact surface. The in vitro mucoadhesivity of CMC-propylene glycol patches were significantly lower than CMC- glycerol based patches. The in vivo permeation of selected PZ patches delivered the drug well above the minimum buccal permeation rate, so as to attain effective blood concentration
Keywords: Buccoadhesive; In vitro mucoadhesion; Pentazocine; Buccal patches Buccoadhesive; In vitro mucoadhesion; Pentazocine; Buccal patches

Share and Cite

MDPI and ACS Style

Sampathkumar, D.; Thilek Kumar, M.; Balasubrarnaniam, J.; Pandit, J.K. Development of Buccoadhesive Systems of Pentarocine for Systemic Drug Delivery. Sci. Pharm. 2003, 71, 281-301. https://doi.org/10.3797/scipharm.aut-03-25

AMA Style

Sampathkumar D, Thilek Kumar M, Balasubrarnaniam J, Pandit JK. Development of Buccoadhesive Systems of Pentarocine for Systemic Drug Delivery. Scientia Pharmaceutica. 2003; 71(4):281-301. https://doi.org/10.3797/scipharm.aut-03-25

Chicago/Turabian Style

Sampathkumar, D., M. Thilek Kumar, J. Balasubrarnaniam, and J. K. Pandit. 2003. "Development of Buccoadhesive Systems of Pentarocine for Systemic Drug Delivery" Scientia Pharmaceutica 71, no. 4: 281-301. https://doi.org/10.3797/scipharm.aut-03-25

APA Style

Sampathkumar, D., Thilek Kumar, M., Balasubrarnaniam, J., & Pandit, J. K. (2003). Development of Buccoadhesive Systems of Pentarocine for Systemic Drug Delivery. Scientia Pharmaceutica, 71(4), 281-301. https://doi.org/10.3797/scipharm.aut-03-25

Article Metrics

Back to TopTop